monitoring by electrocardiography ecg telemetry (Philips Healthcare)
Structured Review

Monitoring By Electrocardiography Ecg Telemetry, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecg+monitoring/6+alice+diagnostic+sleep+system/med_rxiv__64898__2026__03__10__26348048-44-4-57
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Pharmacological enhancement of glymphatic function in humans increases the clearance of Alzheimer’s disease-related proteins"
Article Title: Pharmacological enhancement of glymphatic function in humans increases the clearance of Alzheimer’s disease-related proteins
Journal: medRxiv
doi: 10.64898/2026.03.10.26348048
Figure Legend Snippet: The Dexmedetomidine Trial was conducted at Stanford University’s Clinical and Translational Research Unit (CTRU), while the ACX-02 Clinical Trial was conducted at both Stanford University’s CTRU and Washington State University’s Sleep and Performance Research Center. Both trials used a cross-over design - treatment followed by placebo - to assess the effect of DEX on the glymphatic clearance of Aβ and tau from the brain to the blood. (A) The Dexmedetomidine Trial enrolled nine participants, of whom eight completed both study visits. (B) The ACX-02 Trial enrolled 22 participants, eight at Stanford University and 14 at Washington State University. Of the eight participants at Stanford, six completed both study visits. At Washington State University, 11 of 14 participants completed both study visits. (C) Illustration of the determinants of glymphatic clearance of Aβ and tau during wake, NREM sleep, DEX and ACX-02 treatment. To capture these physiological determinants, participants were instrumented with ECG telemetry, percutaneous oxygen saturation (SpO₂), nasal cannula for low-flow oxygen and continuous end-tidal CO₂ (EtCO₂) monitoring, and a radial arterial line for continuous blood pressure monitoring and blood sampling (Philips IntelliVue MP50). An intravenous line was placed for drug or saline placebo infusion. Participants were also fitted with an investigational in-ear wearable device from Applied Cognition¹⁷ that measured key determinants of glymphatic function, including sleep features (hypnogram and spectral band power) by EEG, heart rate variability (HRV) by photoplethysmography (PPG), cerebrovascular pulse transit time (PTT cereb ) by impedance plethysmography (IPG), and brain parenchymal resistance (R P ) by dynamic electrical impedance spectroscopy.
Techniques Used: Clinical Proteomics, Sampling, Saline, Impedance Spectroscopy
Related Articles
other:Article Title: Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease. Article Snippet: The carotid arteries have been studied with a duplex scanner using a 7.5 Article Title: Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]. Article Snippet: Article history: Received 24 October 2013 Received in revised form 28 January 2014 Accepted 5 February 2014 Available online 18 February 2014 Background: Non-alcoholic fatty liver disease (NAFLD) represents a range of liver conditions from simple fatty liver to progressive end stage liver disease requiring liver transplantation.. NAFLD is common in the population and in certain sub groups (e.g. type 2 diabetes) up to 70% of patients may be affected.. NAFLD is not only a cause of end stage liver disease and hepatocellular carcinoma, but is also an independent risk factor for type 2 diabetes and cardiovascular disease. Article Title: The effect of surgical cure of primary hyperparathyroidism on cardiac electrical activity: a cross−sectional study Article Snippet: ECG monitoring was performed with the Article Title: Infrared thermography for detailed registration of thermoregulation in premature infants. Article Snippet: Objective: To evaluate skin temperature by using different positions with non-contact infrared thermography (IRT) in multiple body areas of preterm infants for detailed information about temperature regulation and distribution.. Methods: The temperature of ten premature infants (median: 27 weeks; age 36 days; weight 1322 g) was determined via IRT (leg, back, arm, head, upper abdomen; diameter 1 cm, scale 0.00 ° C), and comparison was made with two conventional sensors.. There were measurements of 10 min each: first incubator phase (I1), standardized skin-to-skin care (SSC) at the beginning (SSC1), after 90 min (SSC2), and then there was a second incubator phase (I2). |

